Skip to content
contact@indiamedicine.orgLogin / Register
IMSDA
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
Search for:
Menu Close
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us

Knowledge

  1. Home>
  2. News>
  3. Knowledge>
  4. Page 3

Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma

  • Post published:September 13, 2026
  • Post category:Knowledge

The Central Drugs Standard Control Organisation (CDSCO) has been steadily tightening India's drug manufacturing quality standards through the revised Schedule M of the Drugs and Cosmetics Rules. For pharmaceutical manufacturers,…

Continue Reading Schedule M 2026 Explained: GMP Compliance Rules for Indian Pharma

How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India

  • Post published:September 8, 2026
  • Post category:Knowledge

Buying generic medicines in India can save significant money — but quality varies widely between manufacturers. According to the World Health Organization (WHO), generic medicines should be bioequivalent to their…

Continue Reading How to Verify Generic Medicine Quality: A Practical Buyer’s Checklist for India

Understanding India’s NDCT Rules 2026 Amendments: A Guide for Pharma Buyers

  • Post published:September 6, 2026
  • Post category:Knowledge

India's pharmaceutical regulatory landscape is undergoing significant transformation. In January 2026, the Government of India notified key amendments to the New Drugs & Clinical Trials (NDCT) Rules, introducing changes that…

Continue Reading Understanding India’s NDCT Rules 2026 Amendments: A Guide for Pharma Buyers

WHO-GMP Certification for Indian Generic Medicines: A 2026 Buyer’s Complete Guide

  • Post published:September 3, 2026
  • Post category:Knowledge

When you are sourcing generic medicines from India — whether for a hospital formulary, a government tender, or personal use — the WHO-GMP (World Health Organization Good Manufacturing Practice) certification…

Continue Reading WHO-GMP Certification for Indian Generic Medicines: A 2026 Buyer’s Complete Guide
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 67
  • Go to the next page

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
    September 30, 2026/
    0 Comments
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
    September 29, 2026/
    0 Comments
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
    September 28, 2026/
    0 Comments

Follow Us

IMSDA

Recent Posts

  • Understanding CDSCO’s NSQ Drug Quality Alerts: A Buyer’s Guide for 2026
  • CDSCO’s Risk-Based Regulation Push at iPHEX 2026
  • A Buyer’s Guide to WHO-GMP Certified Indian Generic Medicines
  • India’s PLI Bulk Drug Push: Rs 5,210 Crore Invested by June 2026
  • CDSCO’s Digital Drug Regulatory Platform: What Buyers Should Know

Contact Info

  • If you want to touch more medicine sales and distribution resources, you could contact us, or join us.
  • Address:2nd Floor, Bhavani CHS, Dadar West, Mumbai, 400028, Maharashtra.
  • Phone:+91 8048111688
  • Email:contact@indiamedicine.orgOpens in your application
  • Website:https://indiamedicine.org/
  • Home
  • About Us
  • Drugs
  • News
  • Knowledge
  • Members
  • Contact Us
© Copyright All Right Reserve